Fresh Tracks Therapeutics Inc's Customers Performance

Name: Fresh Tracks Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

FRTX

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


FRTX's Source of Revenues		• List of FRTX Customers

for the same period Fresh Tracks Therapeutics Inc

• List of FRTX Customers

Fresh Tracks Therapeutics Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Fresh Tracks Therapeutics Inc's Comment on Sales, Marketing and Customers

The company entered into an Asset Purchase Agreement Amendment with Botanix concerning the sale of certain assets. Botanix is a customer involved in payments totaling $6.6 million to the company and $1.7 million to Bodor. The agreement includes milestone payments linked to regulatory events, such as the FDA acceptance of a new drug application for sofpironium bromide gel, 15%, and potential marketing approvals. Additional success-based regulatory and sales milestone payments of up to $168.0 million, as well as tiered earnout payments based on net sales of sofpironium bromide gel, are included. Botanix is also obligated to pay a portion of sales-based milestone payments and royalties received from Kaken under the assigned Kaken Agreement, referred to as Sublicense Income. These royalties depend on net sales influenced by various market factors. Customers and markets referenced include Bodor, Botanix, and Kaken.

Fresh Tracks Therapeutics Inc’s Comment on Sales, Marketing and Customers

FRTX's Stock Performance relative to it's Customers

FRTX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Fresh Tracks Therapeutics Inc	5.04	6.94	-5.69	28
SUBTOTAL	0.00	0.00	0.00	-

Sources: Fresh Tracks Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Fresh Tracks Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Fresh Tracks Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.